Previous 10 | Next 10 |
DURECT Corporation Appoints Two New Board Members PR Newswire CUPERTINO, Calif. , Jan. 5, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced the appointment of two new members to its board of directors, Gail J. Maderis , MBA and Moha...
DURECT Corporation Announces Closing of LACTEL® Absorbable Polymer Product Line Sale to Evonik and Receipt of $15 Million PR Newswire CUPERTINO, Calif. , Jan. 4, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that the sale of the ...
DURECT Corporation to Participate in Investor Conferences in January 2021 H.C. Wainwright BioConnect 2021 Conference and LifeSci Advisors Corporate Access Event PR Newswire CUPERTINO, Calif. , Dec. 21, 2020 /PRNewswire/ -- DURECT Corporation (Na...
The FDA has granted Fast Track Designation to Durect's (DRRX) DUR-928, lead product candidate in the company's Epigenetic Regulator program, for the treatment of alcoholic hepatitis ((AH)).Fast Track provides for more frequent interaction with the FDA review team and a rol...
DURECT Corporation Announces DUR-928 Granted FDA Fast Track Designation for Treatment of Alcoholic Hepatitis CUPERTINO, Calif. , Dec. 16, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has gran...
DURECT ([[DRRX]] +1.6%) signs an agreement to sell its LACTEL Absorbable Polymer product line to Evonik.Evonik will pay DURECT $15M in exchange for certain assets and liabilities associated with LACTEL product line based in Birmingham, Alabama, plus an additional potential payment b...
DURECT Corporation to Sell its LACTEL® Absorbable Polymer Product Line to Evonik for $15 Million CUPERTINO, Calif. , Dec. 7, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it has signed an agreement to sell its LACTEL Absorbable Poly...
DURECT Corporation Announces Additional Safety Data and Efficacy Signals from Phase 1b Clinical Trial of DUR-928 in NASH Patients at The Liver Meeting Digital Experience™ 2020 PR Newswire CUPERTINO, Calif., Nov. 13, 2020 CUPERTINO, Calif. , Nov. 13, 2020...
DURECT Corporation to Host Webinar on the Treatment of Alcoholic Hepatitis Featuring Chief Medical Officer Dr. Norman Sussman PR Newswire CUPERTINO, Calif., Nov. 10, 2020 CUPERTINO, Calif. , Nov. 10, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ...
DURECT ([[DRRX]] -7.6%) Q3 total revenue $2.7M, compares to $10.8M last year figure.Net loss was $9.3M.At September 30, 2020, cash and investments were $49.8M, compared to cash and investments of $51.3M at June 30.Company continues to communicate with the FDA regarding their review of th...
News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis PR Newswire DURECT plans to confirm the efficacy and safety of larsucosterol in a registrational Phase 3 clinical trial CUPERTINO, Calif. , May ...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 171.6% to $0.1657 on volume of 180,907,472 shares AMC Entertainment Holdings Inc. Class A (AMC) rose 84.4% to $9.57 on volume of 174,658,682 shares Plug Power Inc. (PLUG) rose 45.9%...
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update PR Newswire - FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Ea...